Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Bell's Palsy
Conditions
Bell's Palsy
Trial Timeline
May 1, 2001 → Sep 1, 2007
NCT ID
NCT00510263About Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placebo
Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placebo is a approved stage product being developed by Pfizer for Bell's Palsy. The current trial status is completed. This product is registered under clinical trial identifier NCT00510263. Target conditions include Bell's Palsy.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00510263 | Approved | Completed |